The developmental and tissue-specific regulation of growth hormone receptor (GHR) mRNA expression is complex and involves alternate leader exon usage. The transcript composition of hepatic GHR mRNA has therefore been determined in fetal sheep during late gestation and after experimental manipulation of fetal plasma cortisol levels by fetal adrenalectomy and exogenous cortisol infusion, using RNase protection assays and a riboprobe containing exons 1A, 2, and 3 of the ovine GHR gene. Expression of the adult liver-specific GHR mRNA transcript containing exon 1A was not detected earlier than 138 days of gestation (term 145 ؎2 days). Thereafter, expression of this leader exon increased and accounted for 25-30% of the total GHR mRNA in the fetal liver at term. Hepatic GHR mRNA derived from leader exons other than 1A was detectable at 97 days and increased in abundance toward term in parallel with the normal prepartum rise in fetal plasma cortisol. Abolition of this cortisol surge by fetal adrenalectomy prevented both the activation of exon 1A expression and the prepartum rise in GHR mRNA derived from the other leader exons in fetal ovine liver. Conversely, raising cortisol levels by exogenous infusion earlier in gestation prematurely activated exon 1A expression and enhanced the abundance of GHR mRNA transcripts derived from the other leader exons. Cortisol therefore appears to activate the adult mode of GHR gene expression in fetal ovine liver during late gestation. After birth, growth hormone (GH) 3 has an important role in regulating the growth rate (1). It binds to specific cell surface receptors in the liver and stimulates the production of insulin-like growth factor-I (IGF-I). In turn, IGF-I stimulates cell proliferation in a variety of tissues postnatally (1, 2). By contrast, GH appears to have little part in the control of prenatal growth despite high levels of plasma GH in utero (2). Abnormalities in fetal GH secretion are not associated with major alterations in body size in either human infants or experimental animals (3). Fetal hypophysectomy also has little, if any, effect on fetal plasma IGF levels, although these growth factors remain essential for normal development in utero (3, 4). During the perinatal period, there is therefore a transition in the mechanisms regulating growth from GH independence to dependence on the binding of GH to its receptor in the liver. In sheep, pigs, and rats, this switch has been attributed, at least in part, to the increased availability of GH receptors in hepatic cell membranes after birth (5-7).
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In adults, the GH receptor (GHR) is encoded by a single gene from which multiple mRNA transcripts are derived (8) . Variations in GHR mRNA have been observed in a wide variety of species including primates, rodents, and ungulates (9 -14) . This heterogeneity of GHR gene expression occurs primarily in the 5Ј untranslated region of the GHR mRNA, though deletions of coding exon 3 have also been reported in the human (8) . In the sheep, two untranslated leader exons (1A and 1B) are known to be alternatively spliced to the coding exons whereas, in the human, at least eight variant GHR mRNA transcripts have been identified (9, 13, 15) . Postnatally, the variant GHR mRNA transcripts have been shown to be differentially regulated in both a developmental and tissue-specific manner (9 -15) . Vari-ants that are expressed only in the liver have been identified in several species (12, 16, 17) . In sheep, for instance, it is leader exon 1A expression, which is liver specific (12) .
Much less is known about GHR gene expression in the fetus. Using immunohistochemistry, Northern blotting, and GH binding to isolated membrane preparations, GH receptors have been detected in fetal tissues of a number of species from early in gestation (11, 13, (17) (18) (19) (20) . However, their abundance varies widely between tissues and is low in fetal liver compared with postnatal values (13, 18, 20) . Variant forms of GHR mRNA have also been identified in fetal liver from sheep, humans, and rabbits (13, 16, (21) (22) (23) . Using probes to GHR coding sequences, up-regulation of hepatic GHR gene expression has been observed in fetal sheep and pigs close to term (24 -26) . These changes closely parallel the normal prepartum rise in fetal plasma cortisol and coincide with an increase in GH binding to hepatic cell membranes (5, 7, 27) . In fetal sheep, total hepatic GHR mRNA is known to be regulated by plasma cortisol in utero (24) , but little is known about the effects of cortisol on the transcript composition of the GHR mRNA. Hence, in the present study, expression of the adult liver-specific exon 1A containing transcript of the GHR gene was examined in fetal ovine liver during late gestation and after experimental manipulation of fetal plasma cortisol by fetal adrenalectomy and exogenous cortisol infusion.
MATERIALS AND METHODS

Animals
Twenty-four Welsh Mountain ewes of known gestational age were used in the study. Thirteen of the ewes carried twins whereas the remainder had single fetuses. All fetuses (nϭ37) were alive at delivery.
Surgical procedures
Under halothane anesthesia (1.5% in O 2 /N 2 O), one of two procedures was carried out using the surgical techniques described previously: 1) intravascular catheterization of the intact fetus and ewe (28) or 2) fetal adrenalectomy with or without catheterization of the fetus and ewe (24) . The number of animals in each group and the gestational ages of the fetuses at operation are shown in Table 1 (normal term 145 Ϯ2 days).
Experimental procedures
Blood samples were taken daily from all the catheterized fetuses to monitor fetal well-being. At least 5 days after surgery, 15 intact twin fetuses were infused intravenously with either cortisol (nϭ7, 2-3 mg⅐kg Ϫ1 ⅐day Ϫ1 EF-Cortelan, Glaxo plc, U.K.), or saline (nϭ7, 3 ml/day) for 5 days before delivery. The infusion began either at 105-107 days (nϭ3 pairs of twins) or 122-125 days of gestation (nϭ4 pairs of twins). The fetus to be infused with cortisol was chosen randomly. Similarly, continuous infusions of cortisol or saline (nϭ4 for each group, as above) were given to eight adrenalectomized fetuses for 5 days beginning at 122-126 days. Tissues were collected at the end of the infusion at either 110 -112 days or 127-131 days (Table 1 ).
Autopsy and sample collection
All surgically treated fetuses (regardless of previous treatment) and 11 additional fetuses that were not treated surgically were delivered by Caesarean section under sodium pentobarbitone anesthesia (6% w/v NaCl 20 mg/kg i.v.). Details of the numbers and age of the fetuses at delivery are shown in Table 1 . Blood samples were taken from the fetus at the time of delivery, either through the indwelling catheter or by venipuncture from the umbilical artery. Samples of liver were collected from the fetuses after administering a lethal dose of anesthetic (200 mg/kg i.v. Na pentobarbitone). The tissue was frozen immediately in liquid nitrogen and stored at Ϫ80°C. All blood samples were centrifuged at 4°C and the plasma stored at Ϫ20°C until required for analysis. There were no adrenal remnants in any of the adrenalectomized fetuses at autopsy.
Biochemical analyses
Plasma cortisol concentration
The arterial plasma concentration of cortisol was measured by radioimmunoassay validated for ovine plasma as described previously (24) . The interassay coefficients of variation was 10% and the minimum detectable quantity of hormone was 10 -30 pg/tube.
RNA isolation
Total RNA was isolated from 1 g portion of frozen tissues using the guanidinium thiocyanate method of Chomczynski and Sacchi (29) . Total RNA was quantified by absorbency at 260 nm (1 OD ϭ 40 g). To check equivalence of RNA samples, total poly (A) ϩ content was also measured and quantified using an image analyzer, as described previously (30) . A constant relation between OD and poly (A) ϩ content was found for RNA from all tissues: the mean (Ϯsem) intensity of the poly (A) ϩ RNA hybridization signal from liver of intact fetuses at 143-145 days (42.5 Ϯ2.0 arbitrary units, nϭ4) was not significantly different from that found earlier in gestation (41.5 Ϯ2.0, nϭ4) or from the values observed after fetal adrenalectomy (41.0 Ϯ1.5, nϭ4) and cortisol infusion (39.0 Ϯ2.0, nϭ4).
Construction of riboprobe
A riboprobe containing exons 1A, 2, and 3 of the ovine growth hormone receptor mRNA was constructed by polymerase chain reaction (PCR), using oligonucleotide primers as follows: the 5Ј-ATCT(AAGCTT)CAGCCTCTGTTTCAG-GA-3Ј, comprising a HindIII recognition site (in brackets) and located in the leader exon 1A region between nucleotides 172 and 188 of the published sequence (13) . The 3Ј primer was 5Ј-ATTC(GAATTC)TGTCTCTAGGCCTGGAT-3Ј, comprising an EcoRI recognition site linked to the complement of the DNA sequence of coding region exon 3 of the ovine GHR gene. Using these primers, PCR was performed on cDNA synthesized from total RNA of liver from an adult sheep, as described previously (30) . The product of the 201 bp fragment was digested with EcoRI and HindIII, cloned into Bluescript KS (Strategene Ltd., Cambridge, U.K.), and the sequence was verified by double-stranded sequencing. The plasmid DNA was linearized by HindIII digestion and used as a template to generate antisense riboprobe in an in vitro transcription system by using T7 RNA polymerase.
RNase protection assay
The riboprobe was synthesized in the presence of ␣-32 P-UTP (ICN, Irvine, Calif.) to yield a labeled antisense RNA probe and RNase protection assays were performed on either 25 or 50 g of individual liver RNA samples, exactly as described before (30) . Protected fragments were separated on 6% polyacrylamide sequencing gels; the dried gels were exposed to X-ray film (Kodak, Cambridge, U.K.) and the intensities of the protected bands quantified using an image analyzer (Seescan Imaging, Cambridge, U.K.). To allow data from different experiments to be combined, a standard reference sample was included in each gel and used to normalize values from separate gels.
Statistical analysis
Means and standard errors are given throughout and statistical analysis were made according to the methods of Armitage (31) . Statistical significance was assessed by one way ANOVA, paired and unpaired t test with Fisher's test. Undetectable values for exon 1A expression were assigned a value of 0.05 for the purposes of statistical analyses. Probabilities of less than 5% were considered significant.
RESULTS
Ontogenic expression of leader exon 1A of the GHR gene during late gestation
To determine differential leader exon expression of the ovine GHR gene, RNase protection analysis was carried out with a riboprobe containing the sequences of leader exon 1A and coding exons 2 and 3. In principle, all leader exon 1A-derived GHR mRNAs will give full protection with this riboprobe, whereas mRNA derived from other leader exons will protect only the regions of the probe containing exons 2 and 3. Using the probe, two protected bands were observed-one of 181 bases representing full-length protection by leader exon 1A-containing GHR mRNA transcripts and a second, smaller product of 146 bases, arising from protection of exons 2 and 3 alone (Fig. 1) . Simultaneous monitoring of expression of alternative leader exon-derived transcripts is therefore possible in a single analysis (Fig. 1) .
At all gestational ages studied, the predominant GHR mRNA transcripts were those derived from leader exons other than 1A (Fig. 1) . Leader exon 1A-containing GHR mRNA was not detectable before 130 days and first appeared in fetal liver at about 138 days of gestation (Fig. 1) . Thereafter, expression of this leader exon rose to account for 30.0 Ϯ7.6% (nϭ4) of the total GHR mRNA at term (Fig. 2) . However, even at 143-145 days, abundance of the leader exon 1A-containing transcripts was 10-fold less than seen in adult liver (Fig. 1) . Levels of GHR mRNA derived from the other leader exons also increased in fetal liver toward term (Fig. 1) ; mean abundance of the 146 base band at 143-145 days was similar to that in adult liver (Fig. 1) and significantly higher than the values observed earlier in gestation Figure 1 . Analysis of the ontogeny of GHR mRNA in total RNA from fetal ovine liver. Autoradiogram of RNase protection assay using the riboprobe containing exons 1A, 2, and 3 of the ovine GHR gene hybridized with 1) 25 g total RNA from adult liver or 2) with 50 g total RNA from livers of groups of fetuses aged 97-145 days of gestation. Protected probe gives bands at 181 nucleotides for exon 1A-derived GHR mRNA and at 146 nucleotides for GHR mRNA derived from other leader exons. Autoradiograms were exposed for 3 days. (Fig. 2) . Up-regulation of GHR gene expression from both the 1A and other leader exons closely paralleled the normal rise in fetal plasma cortisol concentrations toward term (Fig. 2) .
Manipulation of fetal plasma cortisol
Fetal adrenalectomy
Fetal adrenalectomy abolished the prepartum rise in fetal plasma cortisol ( Table 2 ) and prevented activation of leader exon 1A-derived GHR mRNA expression (Fig. 3a) . At 143-145 days, the mean plasma cortisol in adrenalectomized fetuses was significantly less than that in intact fetuses of the same gestational age and was similar to the values observed in intact fetuses before 130 days (Table 2 ). In contrast to intact fetuses, no leader exon 1A-derived GHR mRNA was detected in liver from adrenalectomized fetuses at 143-145 days (Fig. 3a) nor was there any prepartum increase in GHR mRNA derived from the other leader exons in the adrenalectomized fetuses (Fig. 3a) . In adrenalectomized fetuses at 143-145 days, the mean abundance of GHR mRNA derived from the other leader exons was similar to that in intact and adrenalectomized fetuses at 127-131 days and significantly less than the value observed in intact fetuses of the same gestational age (Table 2) .
Fetal cortisol infusion
At both 110 -112 days and 127-130 days, cortisol infusion into intact fetuses for 5 days raised fetal plasma cortisol at delivery to values similar to those seen in intact fetuses at term ( Table 2) . Expression of GHR leader exon 1A was also activated in the liver of all cortisol infused intact fetuses irrespective of gestational age, although the abundance of the exon 1A-derived GHR mRNA appeared to be less in cortisol infused fetuses than in intact fetuses at term with similar plasma cortisol levels (Fig. 3a, b, d , Table  2 ). The abundance of GHR mRNA derived from the other leader exons was also increased by cortisol infusion in the intact fetuses (Fig. 3b, d ). Mean levels of hepatic GHR mRNA derived from the other leader exons in cortisol infused fetuses at 110 -112 days and 127-130 days were similar to those seen in intact fetuses at term and were significantly greater than the values observed in the corresponding groups of saline-infused intact fetuses (Table 2) . Cortisol infusion had similar effects on fetal plasma cortisol and hepatic GHR mRNA abundance in the adrenalectomized fetuses at 128 -131 days (Fig. 3 , Table 2 ). Expression of GHR mRNA containing leader exon 1A was activated by cortisol infusion in adrenalectomized fetuses (Fig. 3c) . Similarly, the abundance of GHR mRNA transcripts derived from the other leader exons was significantly greater in cortisol-than saline-infused adrenalectomized fetuses at 128 -131 days of gestation (Table 2) .
DISCUSSION
Characterization of the ovine GHR gene has revealed the existence of at least two untranslated leader exons, exon 1A and 1B, which are alternatively spliced to the main coding exons (13, 15, 16) . In adults, leader exon 1A is expressed exclusively in the liver whereas leader exon 1B is found in the liver and other tissues (13, 16) . These previous studies also showed that exon 1A was not expressed in fetal liver until just before birth (13, 15) . Results of the present study demonstrate that expression of exon 1A-derived GHR mRNA in fetal ovine liver during late gestation is cortisol dependent. Appearance of hepatic GHR mRNA containing exon 1A occurred at about 138 days of gestation and coincided with the final rapid rise in fetal plasma cortisol toward term. When this prepartum cortisol surge was prevented by fetal adrenalectomy, activation of leader exon 1A ϩ Significantly greater than values seen at gestational ages Յ130 days. expression close to term did not occur. Conversely, raising cortisol levels when concentrations are normally low prematurely activated leader exon 1A expression in the fetal liver. Cortisol therefore appears to specifically induce expression of the adult liver-specific leader exon 1A in fetal ovine liver during late gestation.
Cortisol also up-regulated hepatic GHR gene expression from other leader exons in the sheep fetus. The normal prepartum increment in GHR mRNA derived from these other leader exons did not occur after fetal adrenalectomy and could be mimicked earlier in gestation by fetal cortisol infusion. In fact, the transcripts derived from the alternate leader exons accounted for the major part of the increment in hepatic GHR mRNA observed toward term and in response to cortisol infusion. Preliminary observations using an exon 1B-specific riboprobe suggest that the GHR mRNA detected in fetal liver is derived predominantly from exon 1B throughout late gestation (J. Li, R. S. Gilmour, and A. L. Fowden, unpublished observations). Consequently, the prepartum increase in hepatic GHR gene expression observed in utero in previous studies using GHR coding sequence probes (13, 21, 24) probably reflects enhanced expression from both the 1A and 1B leader exons. Certainly, the current findings are consistent with previous observations that up-regulation of GHR gene expression toward term may involve two GHR mRNA transcripts differing upstream from the first coding exon (13) .
Similar gestational changes in hepatic GHR gene expression have been observed in other species. In the human, expression of the liver-specific GHR mRNA variant homologous to ovine exon 1A was not observed in fetal liver examined between 11 and 30 wk of gestation but was detected in liver collected 1 wk after birth (17, 33) . There are also ontogenic changes in the other human GHR mRNA variants with loss of the exon 3 deleted isoforms from fetal tissues during the last part of gestation (22) . In pigs, perinatal up-regulation of hepatic GHR gene expression has been demonstrated in studies using probes specific to different regions of the porcine GHR gene (7, 25, 26) . However, the onset and time course of the increment in hepatic GHR mRNA varied with the different probes (7, 25, 26) . Developmental changes in GHR mRNA transcript composition may therefore also occur in the human and pig close to delivery when fetal cortisol levels are rising most rapidly in these species (27) . In the rat, the major perinatal increment in glucocorticoids occurs 3-4 wk after birth at the time of weaning (27) . This is the age at which, GHR 1 , the rat liver-specific GHR mRNA variant homologous to ovine exon 1A-containing transcript, is first detected in rat liver (12) . Glucocorticoids may therefore have an important developmental role in activating expression of the adult liver-specific GHR mRNA variant in many different species.
The mechanisms whereby cortisol induces expression of specific leader exons in the GHR gene are unknown. Leader exon 1A was switched on when fetal cortisol levels exceeded 35 ng/ml whereas expression of the other leader exons showed a more gradual ontogenic increase, which was closely related to fetal plasma cortisol levels over the entire range of concentrations observed in utero during late gestation. Hence, different molecular mechanisms may be used by cortisol to differentially up-regulate specific leader exons. At the transcriptional level, the actions of glucocorticoids are usually mediated by interactions between the hormone-nuclear receptor complex and promoter sequences, termed glucocorticoid response elements (GREs). Sequence analysis of the 5Ј flanking region of ovine GHR leader exon 1A has revealed two putative half site GREs within the immediate 669 bp region 5Ј to the start site for transcription of this exon (16) . By contrast, no glucocorticoid response element has been identified in the 1.3 kb region immediately upstream of the transcription initiation site for the ovine GHR leader exon 1B (15) . However, the upstream region of exon 1B appears to contain a putative half-site for binding the activated thyroid hormone receptor (15) , unlike the equivalent region of exon 1A (12) . Moreover, in several fetal tissues, the maturational effects of cortisol are known to be mediated by thyroid hormones (1-3). Cortisol stimulates deiodination of thyroxine to triiodothyronine (T 3 ) and leads to a concomitant rise in plasma T 3 toward term (27) . Using probes to GHR coding exons, fetal thyroid hormone deficiency has been shown to prevent the normal upregulation of hepatic GHR gene expression in fetal sheep and pigs close to term (25, 34) . Conversely, infusion of T 3 into fetal sheep before term can prematurely elevate hepatic GHR gene expression (34) . Cortisol may therefore regulate hepatic GHR gene expression via both the 1A and 1B leader exons by acting directly on the exon 1A promotor and indirectly through T 3 on exon 1B expression. In addition, other cortisol-dependent transcription factors or endocrine changes, such as the prepartum rise in plasma estradiol (27) , may be involved in regulating GHR gene expression in the fetal liver close to term. Estradiol is known to enhance hepatic GHR mRNA abundance in adult rats primarily through increased expression of the GHR 1 variant, the rat homologue of ovine exon 1A (12, 35) .
Much less is known about the factors regulating GHR gene expression before the prepartum hormonal changes. Earlier in gestation, the hepatic GHR mRNA is derived entirely from leader exons other than 1A and probably originates largely from exon 1B (J. Li, R. S. Gilmour, and A. L. Fowden, unpublished observations). However, thyroid hormone deficiency in utero has little effect on hepatic GHR mRNA abundance in immature fetal sheep and pigs (25, 34) . In postnatal animals, hepatic GHR gene expression has been shown to be influenced by energy status, sex steroids and by IGF-I (35-37). The relatively low levels of IGF-I in utero and the increased exposure to sex steroids during pregnancy may account, in part, for the basal levels of GHR gene expression observed in fetal liver before the prepartum cortisol surge (1, 2) .
The functional significance of alternate splicing in the 5Ј untranslated region of the GHR gene remains obscure. Differences in this region alter the structure of mRNA and modify its stability and translatability accordingly (38). Varying the transcript composition of mRNA may therefore provide a mechanism for altering the amount of protein produced. In sheep, an increase in GH binding to hepatic membranes, and hence in functional GHR protein, occurs during very late gestation (5). This is followed by a marked increase in hepatic GH binding postnatally to reach high levels in the adult (5, 18) . These changes are correlated closely with the present findings for leader exon 1A expression: the first appearance of leader exon 1A-derived GHR mRNA occurs during late gestation, with a further marked up-regulation between birth and adult life. By contrast, the abundance of GHR mRNA derived from other leader exons, including 1B, is similar at birth to that in the adult. Together, these findings suggest that leader exon 1A-derived GHR may be the major contributor to the postnatal increment in hepatic GH binding and GH-dependent IGF-I production. In the sheep, fetus up-regulation of hepatic GHR gene expression close to term and in response to cortisol infusion is certainly associated with a rise in hepatic IGF-I mRNA abundance (24) .
The effects of cortisol on GHR gene expression are in keeping with its other known maturational effects in utero (2) . It has a key role in ensuring the successful transition from parenteral to enteral nutrition at birth and in adapting growth and metabolism to this new pattern of nutrition (27) . By activating the adult mode of GHR gene expression, the prepartum cortisol surge may initiate maturational changes in the somatotrophic axis that result in the onset of GH-dependent growth after birth. However, whereas preterm cortisol infusion replicated the normal prepartum rise in GHR gene expression from leader exons other than 1A, it did not appear to elevate exon 1A expression to the values observed in term fetuses with similar plasma cortisol concentrations. Furthermore, the abundance of GHR mRNA containing exon 1A in fetal liver at term was less than that in adult liver. Factors other than cortisol may, therefore, be involved in enhancing GHR exon 1A expression in ovine liver during the perinatal period. The identity of these factors and the molecular mechanisms by which cortisol acts on the various promotors of the ovine GHR gene remain to be determined.
